Stratos Wealth Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Stratos Wealth Advisors's BIIB Position: Q4 2023 in Review
Stratos Wealth Advisors sold out of Biogen (BIIB) in Q4 2023, closing a stake of 877 shares — an estimated $225K sold.
Stratos Wealth Advisors first reported a position in BIIB in Q4 2018 and held it in 17 quarters. The position peaked at $632K in Q2 2021. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.
- Stratos Wealth Advisors reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
- Stratos Wealth Advisors sold 877 Biogen shares in Q4 2023, an estimated $225K.
- Stratos Wealth Advisors first reported a position in Biogen in Q4 2018 and held it in 17 quarters.
- Stratos Wealth Advisors's Biogen position peaked at $632K in Q2 2021.
- 1,003 funds tracked by Wall St. Rank held Biogen as of Q4 2023.
Based on Stratos Wealth Advisors's 13F filing for Q4 2023, filed 24 Jan 2024.